Pfizer: Plans For Boosters Will Not Divert Supplies From Poorer Nations
Manufacturing Output Could End Vaccine Inequity In 2022
Pfizer has pledged to supply 41% of its COVID-19 vaccine output to developing nations – but warns that these countries still need to sign contracts on time to guarantee supplies.